Results 21 to 30 of about 3,318,202 (320)
Do you know this syndrome? Hand-foot syndrome [PDF]
Anais Brasileiros de Dermatologia, 2017 Hand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces.
Cintia Santos Braghiroli +4 more
doaj +2 more sources
International Journal of Rheumatology, 2014 Introduction. Antitumor necrosis factor-alpha (TNF-α) agents are widely used for treatment of rheumatic and dermatological diseases. We conducted the systematic review and meta-analysis to assess the prevalence of HBV reactivation among patients treated ...
F. Cantini +7 more
semanticscholar +1 more source
Study of Ukrainian price market of medicines for scalp seborrheic dermatitis treatment
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018 Considering mostly long time use of medicines by the patients with scalp seborrheic dermatitis (SSD) the social-economical availability of medications with antiseborrheic activity becomes important and the price of medicine appear as a certain measure.
V. А. Solodovnyk +2 more
doaj +1 more source
Under Development JAK Inhibitors for Dermatologic Diseases
Mediterranean Journal of Rheumatology, 2020 Molecular targeting therapies represent a new exciting era in dermatology. A promising novel drug class, subject of intense research, is Janus kinase (JAK) inhibitors.
N. Sideris +5 more
semanticscholar +1 more source
Dermatological pharmacology: topical agents [PDF]
Medicine, 2009 Topical therapies constitute an important aspect of dermatological treatments. This article covers the principles of topical treatments, the vehicles used and a number of commonly used topical agents, including corticosteroids. Indications for use and common adverse effects of these topical agents are outlined.
Vincent Cy. Li, Mahbub M. U. Chowdhury
openaire +1 more source
Topical Immunomodulation with Diphenlycyclopropenone for Alopecia Areata
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2019 Introduction: Topical immunotherapy with diphenylcyclopropenone is a treatment option for patients with refractory or extensive alopecia areata. The aim of this study was to evaluate the clinical efficacy and tolerability of diphenylcyclopropenone ...
Ana Sofia Borges +3 more
doaj +1 more source
Vincristine-Induced Acrocyanosis and Erythema Pernio
Journal of Primary Care & Community Health, 2023 Introduction: Acrocyanosis and erythema pernio are 2 dermatologic manifestations of vasospastic changes. Primary care providers should consider that these conditions can occur as primary or idiopathic conditions and as secondary conditions related to ...
Hayden T. Middleton +5 more
doaj +1 more source
Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents.
Archives of Dermatology, 2011 OBJECTIVE To report the financial impact of diagnosing and treating the dermatologic toxicities (dTs) that develop in patients receiving targeted anticancer therapies. DESIGN Single-center retrospective and prospective medical record data extraction.
Judy H. Borovicka +7 more
semanticscholar +1 more source
Frontiers in Immunology, 2023 Immune checkpoint inhibitors (ICIs), such as programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), cytotoxic T lymphocyte antigen 4 (CTLA-4) antibodies, etc, have revolutionized cancer treatment strategies, including non-small cell lung cancer ...
Xiangxiao Hu +26 more
doaj +1 more source
A review of non-pharmacologic approaches to enhance the patient experience in dermatologic surgery.
Dermatology Online Journal, 2020 Efforts to increase patient comfort by minimizing pain and anxiety have been shown to improve clinical outcomes, reduce pain thresholds, decrease analgesic requirements and complication risk, strengthen the physician-patient relationship, and increase ...
Jakob Gamboa +3 more
semanticscholar +1 more source